IPO Ideas

Go to page

Browse IPO Ideas — market data, blogs, legal pages, and more.

Ravelcare Limited IPO logo

Ravelcare Limited IPO

BBSMEBSEListed
Listed at
201
+54.62%

Ravelcare Limited IPO is a SME book building IPO. Issue size is 24.10 Cr. Price band is ₹123 to ₹130 per share. Minimum investment is ₹2.60 L. Lot size is 1000 shares. Open from 1 Dec 2025 to 3 Dec 2025. Allotment on 4 Dec 2025. Listing on 8 Dec 2025 at BSE. Managed by Marwadi Ch and arana Intermediaries Brokers Pvt.Ltd. Registrar: Kfin Technologies Limited. Key details for GMP, subscription, price, allotment, and listing in one place.

Official documents: RHP and DRHP.

Ravelcare Limited IPO overview

Ravelcare Limited IPO Key figures

Price band, lot, minimum application, and issue window at a glance.

Price band
₹123 to ₹130
Lot size
1000 shares / lot
Min investment
₹2,60,000
Issue open – close
1 Dec 2025 → 3 Dec 2025

Ravelcare Limited IPO important dates

Issue Opens
1 Dec 2025
Issue Closes
3 Dec 2025
Allotment
4 Dec 2025
Listing
8 Dec 2025

Ravelcare Limited IPO lot size

CategoryLotsSharesAmount
Retail (Min)22,0002,60,000
S-HNI (Min)33,0003,90,000
S-HNI (UPI)33,0003,90,000
S-HNI (Max)77,0009,10,000
B-HNI (Min)88,00010,40,000

Quick Profit Calculator for Ravelcare Limited IPO

Pre-filled: Issue Price = ₹130, Lot Size = 1,000 shares

About Ravelcare Limited IPO

From the company / RHP narrative.

Incorporated in November 2018, Ravelcare Ltd. is a digital-first beauty and personal care (BPC) brand offering a comprehensive range of haircare, skincare, bodycare, and scalp care products tailored to individual needs. The company operates primarily through its website and online marketplaces such as Amazon, Flipkart, and Myntra, along with quick commerce platforms like Blinkit. In FY 2024–25, Ravelcare expanded its presence internationally, catering to customers in the UAE, Australia, Canada, Germany, the USA, and Saudi Arabia. To ensure supply chain reliability and timely product delivery, the company manages logistics and warehousing operations across central Indian states. Additionally, Ravelcare plans to set up its integrated manufacturing facility in Mauje-Peth, Amravati, Maharashtra, with a proposed installed capacity of 1,050 TPA. This facility will house R&D, manufacturing, packaging, warehousing, and distribution under one roof. Product Offerings Ravelcare’s portfolio spans four key segments: Haircare: Includes shampoos, conditioners, masks, oils, and styling products tailored to concerns like hair fall, frizz, and damage from chemical treatments. Products are customized via digital consultations and are sold through online platforms. Skincare comprises cleansers, serums, moisturisers, sunscreens, and treatments for acne, dryness, pigmentation, and sensitivity. Customisation is based on digital skin assessments. Bodycare: Offers body washes and lotions designed for hydration, cleansing, and skin barrier repair, addressing conditions like dryness and sensitivity. Scalp Care: Features targeted treatments such as anti-dandruff tonics, hair growth serums, and approved hair fall control ampoules for issues like dryness, flaking, and buildup. As of June 30, 2025, the company employed 25 professionals across departments. Competitive Strengths Wide and Diversified Customer Base: The company serves a broad domestic and international customer base through a distributed warehousing model and third-party logistics, ensuring fast and reliable delivery. Digital-First Distribution: Operating primarily through D2C channels, Ravelcare reduces dependency on intermediaries and controls the entire customer journey—from discovery to delivery—allowing competitive pricing and consistent service. Customer-Centric Approach: Ravelcare builds strong relationships via a personalised digital consultation process, enabling the brand to understand individual needs and provide tailored product recommendations. Word-of-mouth from satisfied customers drives organic growth. Innovation-Led Product Development: The company continuously innovates based on customer feedback and digital interactions. Product development includes concept ideation, formulation, regulatory compliance, testing, and market positioning, driven by structured consumer insights. With its focus on personalisation, international expansion, and digital innovation, Ravelcare Ltd. positions itself as a modern, data-driven beauty and personal care brand addressing the evolving needs of customers globally.

Ravelcare Limited IPO Issue Objective

How the issuer plans to use IPO proceeds.

Marketing and advertisement expenses toward enhancing the awareness and visibility of the brand Setting up a new manufacturing facility located at Mauje-Peth in Amravati (“Proposed facility”) General Corporate Purposes

Ravelcare Limited IPO FAQs

A quick overview of key terms, dates, and how to track this IPO.

What is Ravelcare Limited IPO?
Ravelcare Limited IPO is a public issue where the company offers its shares to investors through the stock exchange, allowing retail, HNI, and institutional participation.
What is the IPO price band of Ravelcare Limited IPO?
The IPO price band of Ravelcare Limited IPO is ₹₹123 to ₹130 per share, as mentioned in the issue details.
What is the minimum investment required for Ravelcare Limited IPO?
The minimum investment in Ravelcare Limited IPO is ₹2,60,000, based on the applicable lot size for retail investors.
What is the lot size of Ravelcare Limited IPO?
The lot size of Ravelcare Limited IPO is 1000 shares per lot, and applications must be made in multiples of this lot size.
What are the opening and closing dates of Ravelcare Limited IPO?
Ravelcare Limited IPO opens on 1 Dec 2025 and closes on 3 Dec 2025, as per the announced schedule.
What is Ravelcare Limited IPO subscription status?
Ravelcare Limited IPO subscription status shows the level of demand across retail, HNI, and institutional investor categories during the issue period.
What is Ravelcare Limited IPO GMP today?
Ravelcare Limited IPO GMP (Grey Market Premium) today is around ₹TBA, reflecting current grey market activity before listing.
Is Ravelcare Limited IPO GMP positive or negative?
Ravelcare Limited IPO GMP is currently subject to change, based on prevailing grey market trends. GMP may change over time.
What does Ravelcare Limited IPO GMP indicate for listing?
A positive Ravelcare Limited IPO GMP may indicate market interest ahead of listing, while actual listing performance depends on subscription response and market conditions.
When is Ravelcare Limited IPO listing date?
The expected listing date of Ravelcare Limited IPO is 8 Dec 2025, subject to completion of the allotment process.
Where can I check Ravelcare Limited IPO allotment status?
Ravelcare Limited IPO allotment status can be checked online once the allotment process is completed using application or PAN details.
Can Ravelcare Limited IPO subscription and GMP change before listing?
Yes, Ravelcare Limited IPO subscription figures and GMP may change during the issue period and before listing based on market activity.

Ravelcare Limited IPO Ratings & reviews

Community ratings and reviews — not financial advice.

No ratings yet — be the first to share your experience.

Loading ratings…
Follow the latest IPO & unlisted research on iOS and Android.